Answers are grounded in this paper and cite their sources.
Rhinosinusitis is defined on the basis of the four cardinal symptoms of obstruction, drainage, smell loss, and facial pain or pressure in both acute (ARS) and chronic (CRS) rhinosinusitis, with CRS distinguished by a duration of symptoms of 3 or more months. The determinants of progression from ARS to CRS remain underexplored, but CRS differs from ARS in microbiology, with the most commonly cultured ARS pathogens rarely found in CRS. For the diagnosis of CRS, guidelines further recommend that symptoms be accompanied by objective evidence of sinus inflammation on the basis of sinus computed tomography (CT) scan or nasal endoscopy (1–3). These recommendations were necessary because it remains difficult to accurately differentiate whether a patient presenting with a chief complaint of 4 months of symptoms of facial pain or pressure, bilateral nasal obstruction, and nasal discharge has recurrent ARS, CRS, allergic rhinitis, or migraine without results from diagnostic tests such as nasal endoscopy, a CT scan, or atopy testing. Using symptoms alone, it is also difficult to differentiate important clinical subtypes of CRS such as CRS with nasal polyps (CRSwNP). Indeed, studies from tertiary care institutions report that only about half the patients with characteristic CRS symptoms have objective evidence of sinus inflammation (4, 5). Because diagnosis at the point of encounter has significant impact on treatment, the assumption of a CRS diagnosis on the basis of characteristic symptoms alone likely leads to excessive diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: